Pre-transplant serum concentrations of anti-endothelial cell antibody in panel reactive antibody negative renal recipients and its impact on acute rejection

Clinical Chemistry and Laboratory Medicine

Volumn 47, Issue 10, 2009, Pages 1265-1269

  Han, Fei ^a   Lv, Rong ^a   Jin, Juan ^a   Wu, Jianyong ^a   Chen, Ying ^a   Wang, Huiping ^a   Chen, Jianghua ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

Acute rejection (AR); Antibody; Endothelial cell; Kidney; Transplantation

Indexed keywords

AZATHIOPRINE; CD30 ANTIGEN; CYCLOSPORIN A; ENDOTHELIAL CELL ANTIBODY; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PANEL REACTIVE ANTIBODY; PREDNISOLONE; TACROLIMUS; VIRUS ANTIGEN;

ACUTE GRAFT REJECTION; ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CHILD; COMPLEMENT DEPENDENT CYTOTOXICITY; CONTROLLED STUDY; CYTOMEGALOVIRUS; DIAGNOSTIC VALUE; DIALYSIS; DISEASE COURSE; DISEASE SEVERITY; DRUG SUBSTITUTION; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GRAFT RECIPIENT; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY ALLOGRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; SCHOOL CHILD; SERUM; SEX DIFFERENCE; T LYMPHOCYTE;

ADULT; AUTOANTIBODIES; BLOOD CHEMICAL ANALYSIS; CASE-CONTROL STUDIES; CELL LINE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GRAFT REJECTION; HUMANS; KIDNEY TRANSPLANTATION; MALE; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS;

CYTOMEGALOVIRUS;

EID: 70349829514     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/CCLM.2009.283     Document Type: Article

References (25)

1. Cerilli J, Brasile L, Galouzis T, Lempert N, Clarke J. The vascular endothelial cell antigen system. Transplantation 1985;39:286-289
2. Pober JS, Orosz CG, Rose ML, Savage CO. Can graft endothelial cells initiate a host anti-graft immune response? Transplantation 1996;61:343-349
3. Rose ML. Endothelial cells as antigen-presenting cells: role in human transplant rejection. Cell Mol Life Sci 1998;54:965-978
4. Salom RN, Maguire JA, Hancock WW. Endothelial activation and cytokine expression in human acute cardiac allograft rejection. Pathology 1998;30:24-29
5. Cerilli J, Clarke J, Doolin T, Cerilli G, Brasile L. The significance of a donor-specific vessel crossmatch in renal transplantation. Transplantation 1988;46:359-362
6. Del Papa N, Guidali L, Sironi M, Shoenfeld Y, Mantovani A, Tincani A, et al. Anti-endothelial cell IgG antibodies from patients with Wegener's granulomatosis bind to human endothelial cells in vitro and induce adhesion molecule expression and cytokine secretion. Arthritis Rheum 1996;39:758-766
7. van der Zee JM, Heurkens AH, van der Voort EA, Daha MR, Breedveld FC. Characterization of anti-endothelial antibodies in patients with rheumatoid arthritis complicated by vasculitis. Clin Exp Rheumatol 1991;9:589-594
8. Carvalho D, Savage CO, Black CM, Pearson JD. IgG antiendothelial cell autoantibodies from scleroderma patients induce leukocyte adhesion to human vascular endothelial cells in vitro. Induction of adhesion molecule expression and involvement of endothelium-derived cytokines. J Clin Invest 1996;97:111-119
9. Sumitran-Karuppan S, Tyden G, Reinholt F, Berg U, Moller E. Hyperacute rejections of two consecutive renal allografts and early loss of the third transplant caused by non-HLA antibodies specific for endothelial cells. Transpl Immunol 1997;5:321-327
10. Dragun D. Humoral responses directed against nonhuman leukocyte antigens in solid-organ transplantation. Transplantation 2008;86:1019-1025
11. Opelz G. Non-HLA transplantation immunity revealed by lymphocytotoxic antibodies. Lancet 2005;365:1570-1576
12. Lucchiari N, Panajotopoulos N, Xu C, Rodrigues H, Ianhez LE, Kalil J, et al. Antibodies eluted from acutely rejected renal allografts bind to and activate human endothelial cells. Hum Immunol 2000;61:518-527
13. Fredrich R, Toyoda M, Czer LS, Galfayan K, Galera O, Trento A, et al. The clinical significance of antibodies to human vascular endothelial cells after cardiac transplantation. Transplantation 1999;67:385-391
14. Iv R, He Q, Wang HP, Jin J, Chen Y, Chen JH. High serum level of the soluble CD30 identifies Chinese kidney transplant recipients at high risk of unfavorable outcome. Transplant Proc 2008;40:3375-3380
15. Solez B, Colvin RB, Racusen LC, Sis B, Halloran PF, Birk PE, et al. Banff'05 meeting report: differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy ('CAN'). Am J Transplant 2007; 7:518.
16. Edgell CJ, McDonald CC, Graham JB. Permanent cell line expressing human factor VIII-related antigen established by hybridization. Proc Natl Acad Sci USA 1983;80: 3734-3737
17. Glotz D, Lucchiari N, Pegaz-Fiornet B, Suberbielle-Boissel C. Endothelial cells as targets of allograft rejection. Transplantation 2006;82:S19-21.
18. Sun Q, Liu Z, Yin G, Chen H, Chen J, Li L. Detectable circulating antiendothelial cell antibodies in renal allograft recipients with C4d-positive acute rejection: a report of three cases. Transplantation 2005;79:1759-1762
19. Sun Q, Liu Z, Chen J, Chen H, Wen J, Cheng D, et al. Circulating anti-endothelial cell antibodies are associated with poor outcome in renal allograft recipients with acute rejection. Clin J Am Soc Nephrol 2008;3:1479-1486
20. Toyoda M, Galfayan K, Galera OA, Petrosian A, Czer LS, Jordan SC. Cytomegalovirus infection induces antiendothelial cell antibodies in cardiac and renal allograft recipients. Transpl Immunol 1997;5:104-111
21. Toyoda M, Petrosian A, Jordan SC. Immunological characterization of anti-endothelial cell antibodies induced by cytomegalovirus infection. Transplantation 1999;68: 1311-1318
22. Praprotnik S, Blank M, Meroni PL, Rozman B, Eldor A, Shoenfeld Y. Classification of anti-endothelial cell antibodies into antibodies against microvascular and macrovascular endothelial cells: the pathogenic and diagnostic implications. Arthritis Rheum 2001;44:1484-1494
23. Lidington EA, Moyes DL, McCormack AM, Rose ML. A comparison of primary endothelial cells and endothelial cell lines for studies of immune interactions. Transpl Immunol 1999;7:239-246
24. Suberbielle Boissel C, Mirebeau D, Legendre C, Kssentini M, Kreis H, Charron D, et al. Target antigens of postrejection non-HLA antibodies in renal transplantation. Transplant Proc 1998;30:2853. (Pubitemid 28459851)
25. Nakagawa Y, Saito K, Morioka T, Tomita Y, Takahashi K, Oite T. The clinical significance of antibody to vascular endothelial cells after renal transplantation. Clin Transplant 2002;16(Suppl 8):51-57 (Pubitemid 41185574)